JPH0354922B2 - - Google Patents

Info

Publication number
JPH0354922B2
JPH0354922B2 JP61184986A JP18498686A JPH0354922B2 JP H0354922 B2 JPH0354922 B2 JP H0354922B2 JP 61184986 A JP61184986 A JP 61184986A JP 18498686 A JP18498686 A JP 18498686A JP H0354922 B2 JPH0354922 B2 JP H0354922B2
Authority
JP
Japan
Prior art keywords
learning
drug
active ingredient
memory
effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP61184986A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6322520A (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS6322520A publication Critical patent/JPS6322520A/ja
Publication of JPH0354922B2 publication Critical patent/JPH0354922B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
JP61184986A 1986-07-01 1986-08-06 学習促進・記憶増強用薬剤 Granted JPS6322520A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SU864076765A RU2057531C1 (ru) 1986-07-01 1986-07-01 Средство для стимуляции обучения и памяти
SU4076765 1986-07-01

Publications (2)

Publication Number Publication Date
JPS6322520A JPS6322520A (ja) 1988-01-30
JPH0354922B2 true JPH0354922B2 (en]) 1991-08-21

Family

ID=21241130

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61184986A Granted JPS6322520A (ja) 1986-07-01 1986-08-06 学習促進・記憶増強用薬剤

Country Status (9)

Country Link
US (1) US4735953A (en])
JP (1) JPS6322520A (en])
CH (1) CH670952A5 (en])
DE (1) DE3715218A1 (en])
FR (1) FR2600891B1 (en])
GB (1) GB2192129B (en])
IT (1) IT1221905B (en])
LV (1) LV5405A3 (en])
RU (1) RU2057531C1 (en])

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO890328L (no) * 1988-01-26 1989-07-27 Nii Tekhnol I Bezopasnosti Lek Fremgangsmaate for fremstilling av terapeutisk aktive 4-amino-2,3-disubstituert-6,7-dihydro-5h-1-pyrindinderivater.
EP0394950A1 (en) * 1989-04-25 1990-10-31 Sumitomo Pharmaceuticals Company, Limited Pyridine derivatives
US4985560A (en) * 1990-01-12 1991-01-15 American Home Products Corporation Pyridazino(4,5-b)indolizines
RU2024509C1 (ru) * 1991-05-07 1994-12-15 Всероссийский научный центр по безопасности биологически активных веществ Производные 9-аминоакридина или их соли с органическими или неорганическими кислотами, проявляющие психотропную, антиамнестическую и липидрегулирующую активность
US5869088A (en) * 1994-10-24 1999-02-09 Nikken Chemicals Co., Ltd Transdermal administration preparation of a 9-aminocyclopenta (b) quinoline
PL188838B1 (pl) * 1996-08-13 2005-04-29 P N Gerolymatos Sa Zastosowanie kliochinolu do wytwarzania środka farmaceutycznego i środek farmaceutyczny
US5985936A (en) * 1997-12-18 1999-11-16 Forbes Medi-Tech, Inc. Method of preventing and delaying onset of Alzheimer's disease and composition therefor
JP2001106674A (ja) * 1999-05-13 2001-04-17 Nikken Chem Co Ltd 塩酸イピダクリン水和物の製造方法
JP4587529B2 (ja) * 1999-07-09 2010-11-24 興和創薬株式会社 イピダクリン及び塩酸イピダクリン水和物の製造方法
WO2001004094A1 (fr) * 1999-07-09 2001-01-18 Nikken Chemicals Co., Ltd. Procedes de preparation d'ipidacrine ou d'hydrochlorure d'ipidacrine hydrate
US20050063998A1 (en) * 1999-10-26 2005-03-24 Francois Marc Karel Jozef Oral solution containing galantamine and a sweetening agent
JP2004292316A (ja) * 2000-12-25 2004-10-21 Nikken Chem Co Ltd アルツハイマー型痴呆の日常生活動作能力改善剤
RU2213565C1 (ru) * 2002-06-24 2003-10-10 Общество с ограниченной ответственностью "Паркинфарм" Способ лечебного воздействия на организм пациента при лечении болезни паркинсона
US9132135B2 (en) * 2004-09-24 2015-09-15 University Of Maryland, Baltimore Method of treating organophosphorous poisoning
US7888346B2 (en) * 2004-09-24 2011-02-15 Universtiy of Maryland, Baltimore Method of treating organophosphorous poisoning
RU2327480C1 (ru) * 2007-05-23 2008-06-27 Виктор Иванович Рощин Активный ингредиент лекарственного средства, лекарственное средство, фармацевтическая композиция и способ лечения больных с дементным синдромом

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4550113A (en) * 1982-08-19 1985-10-29 Nauchno-Issledovatelsky Institut Po Biologicheskikm Ispytaniyam Khimicheskikh Soedineny 9-Amino-2,3,5,6,7,8-hexahydro-1H-cyclopenta(b)quinoline monohydrate hydrochloride as stimulant of neuro-muscular transmission of smooth muscles
GB2125696B (en) * 1982-08-23 1985-11-06 Nii Biolog Ispytaniam Khim Soe Compositions containing quinoline derivatives
DE3231571A1 (de) * 1982-08-25 1984-03-01 Naučno-issledovatel'skij institut po biologičeskim ispytanijam chimičeskich soedinenij, Staraja Kupavna, Moskovskaja oblast' Arzneipraeparat als stimulator der nervmuskeluebertragung, der glatten muskel, der erregungsleitung in dem peripherischen und zentralnervensystem

Also Published As

Publication number Publication date
GB2192129B (en) 1991-01-23
FR2600891B1 (fr) 1992-08-14
DE3715218A1 (de) 1988-01-07
CH670952A5 (en]) 1989-07-31
JPS6322520A (ja) 1988-01-30
GB8705317D0 (en) 1987-04-08
LV5405A3 (lv) 1994-03-10
GB2192129A (en) 1988-01-06
RU2057531C1 (ru) 1996-04-10
IT1221905B (it) 1990-07-12
US4735953A (en) 1988-04-05
FR2600891A1 (fr) 1988-01-08
IT8719532A0 (it) 1987-02-27

Similar Documents

Publication Publication Date Title
DE60109589T2 (de) Pharmazeutische zusammensetzung zur behandlung von akutem schmerz, chronischem schmerz und/oder neuropathischem schmerz und migräne
US6187785B1 (en) Agent for treating neurodegenerative disorders
DE69815090T2 (de) Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen
JPH0354922B2 (en])
US5962535A (en) Composition for alzheimer's disease
JP2002532393A (ja) エキソ−ｒ−メカミラミン製剤および治療におけるその使用
KR20170137910A (ko) 제약 분야에서의 r―옥시라세탐 응용
JPS63185927A (ja) 薬物中毒治療のための医薬
EP0275668A2 (en) Use of ketone derivatives in the treatment of cognitive disorders
JPH0133082B2 (en])
CN109069468A (zh) 纯5-ht6受体拮抗剂与乙酰胆碱酯酶抑制剂的组合
KR102023748B1 (ko) 순수한 5-ht6 수용체 길항제 및 nmda 수용체 길항제의 조합물
JP6629464B2 (ja) 純粋な５−ｈｔ６受容体アンタゴニスト、アセチルコリンエステラーゼ阻害剤及びｎｍｄａ受容体アンタゴニストの３種類の組合せ
MXPA06015196A (es) Tratamiento del dolor neuropatico, la fibromialgia o la artritis reumatoide.
EP0471388B1 (de) Mittel zur Behandlung der Herzinsuffizienz
CN113694055B (zh) 沉香四醇在制备治疗血管性痴呆疾病的药物中的应用
WO1991018886A1 (en) Compounds for the treatment of age-related memory impairment and other cognitive disorders
WO1998031356A1 (en) Idebenone containing combination agent for treating alzheimer's disease
JPH0813741B2 (ja) 抗痴呆剤
JP2022554159A (ja) Ｇａｂａａ受容体モジュレーターによるてんかん状態の治療
JPH10259126A (ja) アルツハイマー病治療・予防剤
JP2023012557A (ja) 新規肝性脳症治療剤
RU2693633C1 (ru) Фармацевтическая композиция для лечения последствий черепно-мозговой травмы и способ её получения (варианты)
US3961064A (en) Pharmaceutical composition for remedy of hyperammoniemia
US20070054940A1 (en) Remedy for down's syndrome

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees